Table of Content


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers:
4.1.1.1. Rising approvals of nanotechnology drug delivery system
4.1.1.2. Increasing technological advancements
4.1.2. Restraints:
4.1.2.1. Increasing environmental and health risk
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Regulatory Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
6. By Technology
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
6.1.2. Market Attractiveness Index, By Technology Segment
6.2. Micelles for Nanotechnology in Drug Delivery the industry
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
6.3. Nanoparticles
6.4. Liposomes
6.5. Nanocrystals
6.6. Others
7. By Applications
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications Segment
7.1.2. Market Attractiveness Index, By Applications Segment
7.2. Anti-infective
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Neurology
7.4. Anti-inflammatory/Immunology
7.5. Oncology
7.6. Cardiovascular/Physiology
7.7. Others
8. By Region
8.1. Introduction
8.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.2.5.1. U.S.
8.2.5.2. Canada
8.2.5.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.3.5.1. Germany
8.3.5.2. U.K.
8.3.5.3. France
8.3.5.4. Italy
8.3.5.5. Spain
8.3.5.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.4.5.1. Brazil
8.4.5.2. Argentina
8.4.5.3. Rest of South America
8.5. Asia Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.5.5.1. China
8.5.5.2. India
8.5.5.3. Japan
8.5.5.4. Australia
8.5.5.5. Rest of Asia Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
9. Competitive Landscape
9.1. Key Developments and Strategies
9.2. Company Share Analysis
9.3. Technologys Benchmarking
9.4. List of Key Companies to Watch
10. Company Profiles
10.1. AbbVie Inc.
10.1.1. Company Overview
10.1.2. Technology Portfolio and Description
10.1.3. Key Highlights
10.1.4. Financial Overview
10.2. Cristal Therapeutics
10.3. CYTIMMUNE SCIENCES, Inc.
10.4. Nanobiotix
10.5. NanoCarrier Co. Ltd.
10.6. NanOlogy LLC
10.7. EnColl Corporation
10.8. EyePoint Pharmaceuticals
10.9. Ceramisphere Health Pvt Limited
10.10. Aquanova AG
10.11. BlueWillow Biologics
10.12. Camurus AB
10.13. Celgene, Inc.
10.14. Lena Nanoceutics Ltd.
LIST NOT EXHAUSTIVE
11. Global Nanotechnology in Drug Delivery Market – DataM
11.1. Appendix
11.2. About Us and Applications
11.3. Contact Us